TREA

87937170 - AFFIMER XT

Follow

Information

  • Trademark
  • 87937170
  • Serial Number
    87937170
  • Filing Date
    May 25, 2018
    6 years ago
  • Transaction Date
    January 29, 2024
    a year ago
  • Status Date
    July 04, 2022
    2 years ago
  • Published for Opposition Date
    April 07, 2020
    4 years ago
  • Location Date
    June 02, 2020
    4 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    IN, SUNG HYUN
  • Attorney Name
    Alexandra MacKay
    Law Office Assigned Location Code
    L30
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
AFFIMER XT
Case File Statements
  • GS0051: Reagents for use in veterinary and medical diagnostic tests except tests in the field of immunohematology and transfusion medicine; reagents for use in medical and veterinary research except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for use in medical and veterinary screening except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of biological samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic reagents for medical and veterinary diagnostic purposes for use in assays of samples, particularly blood except tests in the field of immunohematology and transfusion medicine; diagnostic preparations for medical and veterinary diagnostic purposes for use in relation to food intolerance testing; pharmaceutical substances based on affinity reagents equivalent to antibodies, and products comprising them, all for use in medical and/or veterinary screening except tests in the field of immunohematology and transfusion medicine; pharmaceutical preparations in the nature of antigens for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancer, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohemotology and transfusion medicine; diagnostic and/or pharmaceutical preparations containing antigens except preparations in the field of immunohematology and transfusion medicine, for use in medical and veterinary treatment in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases, and genetic conditions; pharmaceutical preparation in the nature of substrates impregnated with or carrying antigens for medical diagnostic use and veterinary diagnostic use and pharmaceutical purposes other than immunohematology and transfusion medicine for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing; affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use and/or pharmaceutical purposes for the detection of cancers, inflammatory diseases, food allergies, infections, autoimmune disorders and for immunity testing but not immunohematology and transfusion medicine; pharmaceutical or diagnostic preparations containing affinity reagents, namely, protein binding agents equivalent to antibodies except in connection with immunohematology or transfusion medicine for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; pharmaceutical preparations in the nature of substrates impregnated with or carrying affinity reagents, namely, protein binding agents equivalent to antibodies for medical diagnostic use and veterinary diagnostic use in the nature of anti-infectives, cancer immunotherapies, anti-inflammatory diseases and genetic conditions; wound dressings; medical plasters; antiseptic wipes; diagnostic reagents for medical use except in connection with immunohematology and transfusion medicine containing any of the aforesaid products; food intolerance test kits comprising diagnostic test patches for application to the skin for determining allergies; reagents, namely, protein binding agents for use in scientific research; reagents, namely, protein binding agents for use in scientific screening; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals; genetic testing kits comprised of reagents for medical purposes; genetic testing kits comprised of reagents for medical purposes for animals
Case File Event Statements
  • 7/5/2022 - 2 years ago
    46 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 7/4/2022 - 2 years ago
    45 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 12/4/2021 - 3 years ago
    44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/2/2021 - 3 years ago
    43 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/2/2021 - 3 years ago
    42 - SOU EXTENSION 3 FILED Type: EXT3
  • 12/2/2021 - 3 years ago
    41 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/27/2021 - 3 years ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/25/2021 - 3 years ago
    39 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 5/25/2021 - 3 years ago
    38 - SOU EXTENSION 2 FILED Type: EXT2
  • 5/25/2021 - 3 years ago
    37 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/3/2020 - 4 years ago
    36 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/1/2020 - 4 years ago
    35 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/1/2020 - 4 years ago
    34 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/1/2020 - 4 years ago
    33 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/2/2020 - 4 years ago
    32 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 4/7/2020 - 4 years ago
    31 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/7/2020 - 4 years ago
    30 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/18/2020 - 4 years ago
    29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/29/2020 - 4 years ago
    28 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/6/2020 - 5 years ago
    27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/6/2020 - 5 years ago
    26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/6/2020 - 5 years ago
    25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/6/2019 - 5 years ago
    24 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/6/2019 - 5 years ago
    23 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/6/2019 - 5 years ago
    22 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/29/2019 - 5 years ago
    21 - PREVIOUS ALLOWANCE COUNT WITHDRAWN Type: ZZZX
  • 6/18/2019 - 5 years ago
    20 - WITHDRAWN FROM PUB - OG REVIEW QUERY Type: PBCR
  • 6/3/2019 - 5 years ago
    19 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 5/31/2019 - 5 years ago
    18 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 5/23/2019 - 5 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/15/2019 - 5 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/15/2019 - 5 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/15/2019 - 5 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 5/8/2019 - 5 years ago
    13 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 4/10/2019 - 5 years ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 4/10/2019 - 5 years ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/10/2019 - 5 years ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/20/2019 - 5 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/20/2019 - 5 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/20/2019 - 5 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/24/2018 - 6 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/24/2018 - 6 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/24/2018 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/15/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/3/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/29/2018 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP